Oracle Expands Clinical Safety Monitoring and Reporting Capabilities With Oracle Argus 8.0 Solutions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wedbush Cuts Price Target Following Oracle (ORCL) EPS Miss
June 18, 2015 8:33 AM EDTWedbush maintains a Neutral rating on Oracle (NYSE: ORCL), and cut the price target to $40.00 (from $42.00), following F4Q results. ORCL reported EPS of $0.78 compared to $0.86 consensus. ORCL guided EPS to $0.56-$0.59.
Analyst Steve Koenig commented, "ORCL missed consensus... More
Cantor Fitzgerald Remains Bullish Following Oracle (ORCL) F4Q15 Results
June 18, 2015 8:12 AM EDTCantor Fitzgerald reiterates a Buy rating and $48.00 price target on Oracle (NYSE: ORCL) following F4Q15 results. EPS of $0.78 fell short of consensus at $0.86. Oracle expects nonGAAP sales to be up 5-8% YoY in CC and pro forma EPS in CC to be $0.56-0.59.... More
Jefferies Reiterates Hold Following Oracle (ORCL) F4Q Miss
June 18, 2015 7:36 AM EDTJefferies maintains a Hold rating and $41.00 price target on Oracle (NYSE: ORCL) following F4Q results. Reported Non-GAAP EPS of $0.78 was below consensus of $0.87. ORCL reported revenues of $10.706B, compared to $10.972B consensus.
Analyst John DiFucci commented, "ORCL reported F4Q results... More
